focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBr.smaller Cos. Regulatory News (BSV)

Share Price Information for Br.smaller Cos. (BSV)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 80.00
Bid: 78.50
Ask: 81.50
Change: 0.00 (0.00%)
Spread: 3.00 (3.822%)
Open: 80.00
High: 80.00
Low: 80.00
Prev. Close: 80.00
BSV Live PriceLast checked at -
British Smaller Companies VCT is an Investment Trust

To maximise Total Return and provide investors with an attractive long-term tax-free dividend yield while maintaining the Company's status as a venture capital trust.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

3rd Quarter Results

21 Mar 2022 13:15

RNS Number : 4701F
British Smaller Companies VCT PLC
21 March 2022
 

British Smaller Companies VCT plc

Interim Management Statement

For the quarter ended 31 December 2021

British Smaller Companies VCT plc (the "Company") presents its interim management statement for the quarter ended 31 December 2021. The statement also includes relevant financial information between the end of the quarter and the date of this statement. A copy of this interim management statement can be found at www.bscfunds.com.

Overview

The Company's Total Return at 31 December 2021 was 251.9 pence per ordinary share, representing an increase of 1.6 pence per ordinary share over the Total Return of 250.3 pence per ordinary share as at 30 September 2021. The increase is 1.8 per cent of the opening net asset value at the beginning of the quarter of 90.9 pence per share.

The Company completed the realisation of 15 per cent of its investment in Matillion as part of its Series E funding round during the quarter. The proceeds from this partial exit were £5.0 million which, together with previous proceeds received of £2.1 million, represents a total return to date of 2.7x the total cost of the Company's investment. The value of the Company's residual investment in Matillion at 31 December 2021 is £29.7 million. This is an outstanding outcome to date, in a company which is experiencing continued fast growth.

Total proceeds from all full and partial realisations in the quarter were £6.4 million, a gain of £3.5 million over cost. £0.2 million was invested in the quarter.

Following its previously announced offer for subscription (alongside British Smaller Companies VCT2 plc, together "the Offers"), on 7 January 2022 the Company made the first and final issue of ordinary shares pursuant to the Offers by allotting 39,514,174 ordinary shares of 10 pence each, raising gross proceeds of £34.6 million (£33.2 million net).

Performance

The movement in Total Return in pence per ordinary share is set out in the table below:

 

30 September 2021

Increase in Value

Dividends paid/shares issued

Buyback of shares

Movement

In Period

31 December 2021

Net Assets (£m)

131.7

2.5

(5.4)

(0.4)

(3.3)

128.4

NAV per share (PPS)

90.9

1.6

(5.0)

-

(3.4)

87.5

Cumulative dividends paid (PPS)

159.4

-

5.0

-

5.0

164.4

Total Return (PPS)

250.3

1.6

-

-

1.6

251.9

Shares in issue

144,873,228

-

2,306,826

(526,365)

1,780,461

146,653,689

The unaudited NAV increased in value by 1.6 pence; after payment of 5.0 pence of dividends, the unaudited NAV per ordinary share stood at 87.5 pence per share at the period end. Cumulative dividends paid at 31 December 2021 were 164.4 pence per ordinary share (30 September 2021: 159.4 pence per ordinary share).

 

The movements in NAV per ordinary share are set out in the table below:

 

 

£m

Pence per

ordinary share

NAV at 30 September 2021

131.7

90.9

Increase in portfolio value

3.0

2.0

Net operating costs

(0.5)

(0.4)

2.5

1.6

Issue/buy-back of shares

1.4

-

Total Return in the period

3.9

1.6

NAV before the payment of dividends

135.6

92.5

Dividends paid

(7.2)

(5.0)

NAV at 31 December 2021

128.4

87.5

 

Following payment of the third interim dividend of 2.0 pence per ordinary share for the year ending 31 March 2022 on 5 January 2022 the unaudited net asset value is 85.5 pence per ordinary share.

Dividends and shares in issue

On 16 November 2021, the Company issued 2,306,826 shares under the DRIS, following the payment of the second interim dividend.

 

Under its standing buyback authority, on 15 December 2021 the Company purchased 526,365 shares at 80.21 pence at a cost of £0.42 million. These shares are held in treasury.

 

Subsequent to the quarter end, on 5 January 2022 the Company issued 940,963 shares under the DRIS following the payment of the third interim dividend, and on 7 January 2022 the Company issued 39,514,174 shares arising from the Offers, taking the number of shares in issue to 187,108,826 at that date, with a further 17,986,301 shares held in treasury.

Net assets

Net assets at 31 December 2021 comprised the following:

£000

% of net assets

Unquoted investments at fair value

95,297

74.2

Listed investment funds

5,146

4.0

Cash and cash equivalents

27,056

21.1

Other net current assets

873

0.7

Net assets

128,372

100.0

 

Investments

The investment portfolio at 31 December 2021 comprised:

Valuation

£000

Cumulative valuation as a % of net assets

Matillion Limited

29,655

23.1%

Springboard Research Holdings Limited

5,938

27.7%

Intelligent Office UK

4,744

31.4%

Wooshii Limited

4,743

35.1%

Unbiased EC1 Limited

4,624

38.7%

Elucidat Ltd

4,397

42.1%

SharpCloud Software Limited

4,392

45.6%

Force24 Ltd

4,160

48.8%

ACC Aviation Group Limited

3,661

51.7%

Displayplan Holdings Limited

3,512

54.4%

69,826

54.4%

Other investments

25,471

19.8%

Total investments

95,297

74.2%

Investments made since November 2015 represented 77 per cent of the value of the unquoted portfolio at 31 December 2021.

Portfolio performance

Over the quarter to 31 December 2021, the aggregate portfolio valuation has increased by £3.0 million.

Ukraine

During the build up to and subsequent to the recent invasion of Ukraine by Russia, we have been closely monitoring the impact of the war on our portfolio. There is minimal direct impact, which has principally been where two portfolio companies have had a small section of their software development teams based in Ukraine. From a business perspective, continuity of supply and service has been secured, although we are aware of a small number of developers who we believe are directly caught in the conflict and our thoughts are with them and all those suffering the humanitarian impact of the war.

Outlook

The current environment is clearly a demanding one for many companies, dealing with supply chain inflation, a competitive hiring environment and wider political challenges. But as the pandemic has shown, the key to a company's success is having a strong management team, ready access to capital and remaining agile. We are confident that the Company's portfolio is well placed to navigate these challenges. We also continue to see a number of promising investment opportunities and look forward to updating you on progress with deploying the Company's newly raised funds over the coming quarters.

The information contained within this announcement is deemed by the Company to constitute inside information as stipulated under the Market Abuse Regulations (EU No. 596/2014). Upon the publication of this announcement via Regulatory Information Service this inside information is now considered to be in the public domain.

21 March 2022

For further information please contact:

David Hall YFM Private Equity Limited Tel: 0113 244 1000

Alex Collins Panmure Gordon (UK) Limited Tel: 0207 886 2767

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
QRTEAADFASKAEFA
Date   Source Headline
15th Feb 20199:58 amRNSPayment of dividend and Allotment of shares
11th Feb 201911:15 amRNSClose of Offers to New Applications
11th Feb 201911:15 amRNSClose of Offers to New Applications
28th Jan 20193:00 pmRNSUtilisation of over-allotment facility
28th Jan 20193:00 pmRNSUtilisation of over-allotment facility
7th Jan 20192:15 pmRNSDividend Declaration
7th Jan 20191:15 pmRNSStatement re Prospectus
7th Jan 20191:15 pmRNSStatement re Prospectus
7th Jan 201911:32 amRNSResult of Meeting
21st Dec 20189:10 amRNSDisposal
20th Dec 201810:18 amRNSTransaction in Own Shares
27th Nov 20186:07 pmRNSPublication of Prospectus
27th Nov 20186:07 pmRNSCircular re Incentive Scheme
27th Nov 20185:49 pmRNSPublication of Prospectus
21st Nov 20181:00 pmRNSHalf-year Report to 30 September 2018
23rd Oct 20181:00 pmRNSStatement re proposed joint fundraising
23rd Oct 20181:00 pmRNSStatement re proposed joint fundraising
27th Sep 20181:24 pmRNSTransaction in Own Shares
20th Sep 20183:03 pmRNSDirector/PDMR Shareholding
5th Sep 20182:56 pmRNSAGM Statement
17th Aug 20188:25 amRNSInterim Management Statement
4th Jul 20184:56 pmRNSTransaction in Own Shares
26th Jun 20181:26 pmRNSAnnual Financial Report
18th May 201810:15 amRNSPayment of interim dividend and issue of shares
12th Apr 20188:06 amRNSDividend Declaration
28th Mar 20188:33 amRNSTransaction in Own Shares
2nd Mar 20187:12 amRNSTransaction in Own Shares
26th Feb 20181:51 pmRNSTransaction in Own Shares
23rd Feb 20189:06 amRNSInterim Management Statement
20th Dec 20178:50 amRNSPurchase of own securities and total voting rights
1st Dec 20179:14 amRNSHalf-year Report
28th Sep 20172:59 pmRNSTransaction in Own Shares
23rd Aug 20176:15 pmRNSInterim Management Statement
3rd Aug 20172:04 pmRNSAppointment of non-executive director
2nd Aug 20178:04 amRNSResult of Annual General Meeting
16th Jun 20171:20 pmRNSAnnual Financial Report Announcement
26th May 201711:26 amRNSPayment of Interim Dividend and Issue of Shares
26th Apr 20179:29 amRNSDividend Declaration
30th Mar 20179:14 amRNSPurchase of Own Securities and Total Voting Rights
29th Mar 201711:22 amRNSIssue of Equity and Close of Offer
6th Mar 20173:43 pmRNSClose of Offer to New Subscriptions
28th Feb 201710:17 amRNSStatement re Offer for Subscription
10th Feb 201711:54 amRNSInterim Management Statement & Launch of Offer
18th Jan 201710:04 amRNSPayment of Dividend and Allotment of Shares
6th Dec 201610:03 amRNSHalf-year Report
28th Nov 20167:04 amRNSDisposal
5th Aug 20169:55 amRNSPayment of dividends and allotment of shares
28th Jul 20168:56 amRNSInterim Management Statement
27th Jul 20163:02 pmRNSResult of AGM
8th Jul 201611:27 amRNSCompletion of new investment

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.